AXT, Inc.
AXT, Inc. (AXTI) Financial Performance & Income Statement Overview
Analyze AXT, Inc. (AXTI) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
AXT, Inc. (AXTI) Income Statement & Financial Overview
Access detailed annual and quarterly income data for AXT, Inc. AXTI financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $19.36M | $25.11M | $23.64M | $27.92M |
| Cost of Revenue | $20.60M | $20.70M | $17.96M | $20.27M |
| Gross Profit | -$1.24M | $4.41M | $5.68M | $7.65M |
| Gross Profit Ratio | -$0.06 | $0.18 | $0.24 | $0.27 |
| R&D Expenses | $3.12M | $4.13M | $3.44M | $3.76M |
| SG&A Expenses | $5.92M | $6.44M | $5.65M | $5.78M |
| Operating Expenses | $9.03M | $10.57M | $9.09M | $9.54M |
| Total Costs & Expenses | $29.63M | $31.27M | $27.05M | $29.81M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $269000.00 | $318000.00 | $391000.00 | $282000.00 |
| Depreciation & Amortization | $2.22M | $2.24M | $2.30M | $2.25M |
| EBITDA | -$7.45M | -$2.98M | $426000.00 | $1.45M |
| EBITDA Ratio | -$0.38 | -$0.12 | $0.02 | $0.05 |
| Operating Income | -$10.28M | -$6.17M | -$3.41M | -$1.89M |
| Operating Income Ratio | -$0.53 | -$0.25 | -$0.14 | -$0.07 |
| Other Income/Expenses (Net) | $333000.00 | $621000.00 | $1.15M | $807000.00 |
| Income Before Tax | -$9.94M | -$5.54M | -$2.26M | -$1.08M |
| Income Before Tax Ratio | -$0.51 | -$0.22 | -$0.10 | -$0.04 |
| Income Tax Expense | $74000.00 | $113000.00 | $626000.00 | $121000.00 |
| Net Income | -$8.80M | -$5.09M | -$2.94M | -$1.52M |
| Net Income Ratio | -$0.45 | -$0.20 | -$0.12 | -$0.05 |
| EPS | -$0.20 | -$0.12 | -$0.07 | -$0.04 |
| Diluted EPS | -$0.20 | -$0.12 | -$0.07 | -$0.04 |
| Weighted Avg Shares Outstanding | $43.55M | $43.38M | $43.16M | $43.09M |
| Weighted Avg Shares Outstanding (Diluted) | $43.55M | $43.38M | $43.16M | $43.09M |
The company's financials show resilient growth, with revenue advancing from $27.92M in Q2 2024 to $19.36M in Q1 2025. Gross profit remained healthy with margins at -6% in Q1 2025 compared to 27% in Q2 2024. Operating income hit -$10.28M last quarter, sustaining a consistent -53% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$7.45M. Net income dropped to -$8.80M, while earnings per share reached -$0.20. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan